Bristol-Myers Squibb to acquire Inhibitex

Bristol-Myers Squibb is buying Inhibitex for $2.5 billion, the companies said.

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

Login or Register to post a comment.